Merck & Co., Inc. is a global healthcare company that operates primarily through two segments: Pharmaceutical and Animal Health. The Pharmaceutical segment generates revenue from a range of human health products, including oncology, immunology, and vaccines, contributing approximately 80% of total revenue. The Animal Health segment, which accounts for about 20% of revenue, focuses on veterinary pharmaceuticals and health management solutions. The company's customers include drug wholesalers, hospitals, managed healthcare providers, and veterinarians. Factors supporting Merck's endurance include its established product portfolio and ongoing research and development efforts, while challenges may arise from patent expirations and competition from generic drugs.
—
Merck & Co., Inc. is a global healthcare company that operates primarily through two segments: Pharmaceutical and Animal Health. The Pharmaceutical segment generates revenue from a range of human health products, including oncology, immunology, and vaccines, contributing approximately 80% of total revenue. The Animal Health segment, which accounts for about 20% of revenue, focuses on veterinary pharmaceuticals and health management solutions. The company's customers include drug wholesalers, hospitals, managed healthcare providers, and veterinarians. Factors supporting Merck's endurance include its established product portfolio and ongoing research and development efforts, while challenges may arise from patent expirations and competition from generic drugs.
—
Daily adjusted close
Merck & Co., Inc. is a global healthcare company that operates primarily through two segments: Pharmaceutical and Animal Health. The Pharmaceutical segment generates revenue from a range of human health products, including oncology, immunology, and vaccines, contributing approximately 80% of total revenue. The Animal Health segment, which accounts for about 20% of revenue, focuses on veterinary pharmaceuticals and health management solutions. The company's customers include drug wholesalers, hospitals, managed healthcare providers, and veterinarians. Factors supporting Merck's endurance include its established product portfolio and ongoing research and development efforts, while challenges may arise from patent expirations and competition from generic drugs.